ARTICLE | Clinical News
Phase II data for Cialis
May 1, 2001 7:00 AM UTC
Lilly Icos, a joint venture between Eli Lilly (LLY) and Icos (ICOS), reported that in two Phase II trials of its Cialis ( IC351) phosphodiesterase 5 ( PDE5) inhibitor in men with erectile dysfunction,...